🔗 Share this article Patients Stopping Weight-Loss Jabs Regain Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise Weight management often requires ongoing approaches. New research suggests that individuals who come off popular weight-loss injections like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle plans. Research printed in a prominent medical journal demonstrates that while obese people frequently drop a large proportion of their body weight while using the jabs, the weight returns at an estimated rate of nearly a kilo each month after stopping. "Users purchasing such medications should be informed of the danger of fast rebound weight gain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb. That rate of recovery implies a return to pre-treatment weight within about a year and a half. Comparing Approaches The study, which looked at 37 of studies involving thousands of participants, contrasted the effects of these new drugs with other pills. The team point out that people who lose weight through dieting generally have a more gradual creep back—approximately 0.1 kg a month—post-intervention. The Reason for the Rapid Rebound Experts suggest the mechanism of the drugs explains the amplified rebound. The injections mimic a body's own chemical called GLP-1, which helps regulate appetite. "Artificially providing the hormone concentrations far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher. "Discontinuation of this medication results in appetite is no longer kept in check, making overeating far more likely." A Lifelong Issue? The NHS recommend the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications. Many experts contend that, due to the likelihood of weight regain, the treatment might need to be ongoing. This view is reinforced by drug manufacturers, who state that the findings "highlight the chronic character of obesity," comparing it to managing conditions like hypertension. User Experiences Users who have stopped the jabs explain a powerful return of appetite. "It was like a switch flipping and I was suddenly ravenous," described one woman. The struggle is exacerbated if patients have not developed sustainable dietary or behavioural modifications during treatment. Growing Interest Survey data suggest that millions of people in the UK have used weight-loss jabs in the past year, with interest being substantial. Adoption is more common among females than males. The middle-aged demographic shows the highest usage rates. A large proportion access the medications through private prescriptions rather than the NHS. In conclusion, researchers stress that while these medications are effective agents for weight loss, they are not a magic fix and maintained weight loss hinges on combined lifestyle support.
Weight management often requires ongoing approaches. New research suggests that individuals who come off popular weight-loss injections like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who end conventional lifestyle plans. Research printed in a prominent medical journal demonstrates that while obese people frequently drop a large proportion of their body weight while using the jabs, the weight returns at an estimated rate of nearly a kilo each month after stopping. "Users purchasing such medications should be informed of the danger of fast rebound weight gain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb. That rate of recovery implies a return to pre-treatment weight within about a year and a half. Comparing Approaches The study, which looked at 37 of studies involving thousands of participants, contrasted the effects of these new drugs with other pills. The team point out that people who lose weight through dieting generally have a more gradual creep back—approximately 0.1 kg a month—post-intervention. The Reason for the Rapid Rebound Experts suggest the mechanism of the drugs explains the amplified rebound. The injections mimic a body's own chemical called GLP-1, which helps regulate appetite. "Artificially providing the hormone concentrations far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher. "Discontinuation of this medication results in appetite is no longer kept in check, making overeating far more likely." A Lifelong Issue? The NHS recommend the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications. Many experts contend that, due to the likelihood of weight regain, the treatment might need to be ongoing. This view is reinforced by drug manufacturers, who state that the findings "highlight the chronic character of obesity," comparing it to managing conditions like hypertension. User Experiences Users who have stopped the jabs explain a powerful return of appetite. "It was like a switch flipping and I was suddenly ravenous," described one woman. The struggle is exacerbated if patients have not developed sustainable dietary or behavioural modifications during treatment. Growing Interest Survey data suggest that millions of people in the UK have used weight-loss jabs in the past year, with interest being substantial. Adoption is more common among females than males. The middle-aged demographic shows the highest usage rates. A large proportion access the medications through private prescriptions rather than the NHS. In conclusion, researchers stress that while these medications are effective agents for weight loss, they are not a magic fix and maintained weight loss hinges on combined lifestyle support.